Eur Rev Med Pharmacol Sci 2021; 25 (5): 2161-2162

DOI: 10.26355/eurrev_202103_25203

Reply Letter – “Safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis”

A. De Vito, G. Madeddu

Department of Medical, Surgical and Experimental Sciences, Unit of Infectious Diseases, University of Sassari, Sassari, Italy. giordano@uniss.it


Free PDF Download

To cite this article

A. De Vito, G. Madeddu
Reply Letter – “Safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis”

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 5
Pages: 2161-2162
DOI: 10.26355/eurrev_202103_25203